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The gut microbiota has been implicated in cardiovascular disease (CVD) and atherogenesis.1–3 Accumulation of 
cholesterol in the artery wall and immune mechanisms are 
involved in lesion formation, and atherosclerosis is charac-
terized by chronic inflammation that develops over decades.4 
Accordingly, reducing plasma cholesterol levels and inflam-
mation markers by statin or other cholesterol-lowering thera-
pies are associated with a lower risk of CVD.5–7
See accompanying editorial on page 2269
The human gut is inhabited by trillions of bacteria (micro-
biota). Patients with CVD are associated with an altered micro-
biota,8 but whether the commensal microbiota is causally linked 
to atherogenesis remains unresolved. Diet has been described as 
one of the key factors affecting gut microbiota composition.9,10 
Earlier studies in Apoe−/− mice have demonstrated that the effect 
of microbiota on the development of atherosclerosis is depen-
dent on the macronutrient composition of the diet, showing that 
the gut microbiota was protective in mice fed a low cholesterol 
but not in mice fed a high cholesterol diet.11
Recent evidence suggests that bacteria-derived metabolites, 
such as trimethylamine N-oxide (TMAO), may influence the 
disease. TMAO is associated with CVD in humans and with 
atherosclerosis in chow-fed mice.9,12 However, even though the 
association between circulating TMAO and the risk of cardiovas-
cular events has been demonstrated, reports are inconsistent,13 and 
the role of TMAO in metabolic disease is not fully elucidated.14
Materials and Methods
Data available on request from the authors.
Mice and Diet
The mice were maintained under standard specific pathogen-free (con-
ventionally raised [CONV-R]) or germ-free (GF) conditions with a 
12:12-hour light:dark cycle. Starting at the age of 8 weeks, male and 
female apolipoprotein E knockout mice (C57BL/6J Apoe−/−) were 
fed either chow (Envigo TD.130104), chow supplemented with 1.2% 
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Objective—To investigate the effect of gut microbiota and diet on atherogenesis.
Approach and Results—Here, we investigated the interaction between the gut microbiota and diet on atherosclerosis by 
feeding germ-free or conventionally raised Apoe−/− mice chow or Western diet alone or supplemented with choline (which 
is metabolized by the gut microbiota and host enzymes to trimethylamine N-oxide) for 12 weeks. We observed smaller 
aortic lesions and lower plasma cholesterol levels in conventionally raised mice compared with germ-free mice on a 
chow diet; these differences were not observed in mice on a Western diet. Choline supplementation increased plasma 
trimethylamine N-oxide levels in conventionally raised mice but not in germ-free mice. However, this treatment did not 
affect the size of aortic lesions or plasma cholesterol levels. Gut microbiota composition was analyzed by sequencing of 
16S rRNA genes. As expected, the global community structure and relative abundance of many taxa differed between 
mice fed chow or a Western diet. Choline supplementation had minor effects on the community structure although the 
relative abundance of some taxa belonging to Clostridiales was altered.
Conclusions—In conclusion, the impact of the gut microbiota on atherosclerosis is dietary dependent and is associated with 
plasma cholesterol levels. Furthermore, the microbiota was required for trimethylamine N-oxide production from dietary 
choline, but this process could not be linked to increased atherosclerosis in this model.
Visual Overview—An online visual overview is available for this article.  (Arterioscler Thromb Vasc Biol. 2018;38: 
2318-2326. DOI: 10.1161/ATVBAHA.118.311233.)
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choline (Envigo TD.09041), Western diet (D11042101; Research 
Diets), or Western diet supplemented with 1% choline (D11042102; 
Research Diets) for 12 weeks before anaesthetization with isoflurane 
and collection of blood and tissues. All procedures were approved by 
the Ethics Committee on Animal Care and Use in Gothenburg, Sweden.
Blood was collected through vena cava, centrifuged in EDTA-
containing tubes, and plasma was stored in −80°C. The hearts were 
perfused with phosphate buffered saline, put in OCT Cryomount 
(Histolab Products AB, Gothenburg, Sweden) and slowly frozen in 
liquid nitrogen, other tissues were snap-frozen in liquid nitrogen. 
Tissues were stored in −80°C until further analyses.
Atherosclerosis Assessment and 
Macrophage Staining
Aortic roots were sectioned in 8-µm sections using a cryostat and stained 
with Oil Red O and hematoxylin as described previously.15 The lesion 
and vessel areas were defined manually and calculated by an image pro-
gram. Atherosclerosis was expressed as the percentage of the vessel area 
covered by lesion quantified as the mean value of 2 sections per mouse.
Macrophages were stained in aortic root sections with an Alexa Fluor 
594 anti-mouse CD68 antibody (Biolegend, San Diego, CA) diluted 
1:300, and images were taken in an Axio Imager Z2 microscope (Zeiss). 
Stained area representing macrophages was quantified in Adobe Photshop 
CS5 and related to total vessel area, the mean of 2 sections is presented.
Plasma Analyses
TMAO and bile acids were extracted from plasma samples and mea-
sured by ultraperformance liquid chromatography–tandem mass 
spectrometry as described previously.16 Low abundant bile acids, 
<0.1%, were excluded from further analyses. Plasma cholesterol and 
lipids were analyzed as described previously.17
Plasma cytokines were analyzed in duplicate according to the 
manufacturer’s instructions using a V-PLEX Plus Proinflammatory 
Panel 1 (mouse) kit (Meso Scale Discovery), which measures IFN 
(interferon)-γ, IL (interleukin)-1β, IL-2, IL-4, IL-5, IL-6, KC/GRO 
(keratinocyte chemoattractant/growth-regulated oncogene), IL-10, 
IL-12p70, and TNF-α (tumor necrosis factor-α). Meso Scale Discovery 
plates were analyzed in a MESO QuickPlex SQ120 using the software 
Discovery Workbench, version 4.0.12 (Meso Scale Discovery).
Profiling of Cecal Microbiota Composition
Total genomic DNA was isolated from 100-mg cecal content using 
a repeated bead beating method as described previously.18 Briefly, 
samples were placed in Lysing Matrix E tubes (MP Biomedicals) and 
extracted twice in lysis buffer (4% wt/vol SDS; 500 mmol/L NaCl; 
50 mmol/L EDTA; 50 mmol/L Tris·HCl; pH 8) with bead beating at 
5.5 m/s for 45 s in a FastPrep-24 instrument (MP Biomedicals). After 
each bead beating cycle, samples were heated at 85°C for 15 minutes 
and then centrifuged at full speed for 5 minutes at 4°C. Supernatants 
from the 2 extractions were pooled and purified as described previ-
ously.18 Total genomic DNA was eluted in DNA elution buffer (10 
mmol/L Tris·Cl; 0.5 mmol/L EDTA; pH 9.0).
The cecal microbiota composition was profiled by sequencing 
the V4 region of the 16S rRNA gene on an Illumina MiiSeq instru-
ment (llumina RTA v1.17.28; MCS v2.5) with the V2 Illumina 
kit (2×250 bp paired-end reads), as described previously.19 The 
V4 region was amplified using 515F and 806R primers designed 
for dual indexing.20 Two 25-µL polymerase chain reactions were 
pooled, each containing 1× Five Prime Hot Master Mix (5 PRIME 
GmbH), 200 nmol/L of each primer, 0.4 mg/mL BSA, 5% DMSO 
(dimethyl sulfoxide), and 20 ng of genomic DNA. Polymerase 
chain reaction was performed under the following conditions: ini-
tial denaturation for 3 minutes at 94°C, followed by 25 cycles of 
denaturation for 45 s at 94°C, annealing for 60 s at 52°C and elon-
gation for 90 s at 72°C, and a final elongation step for 10 minutes 
at 72°C. Duplicates were combined, purified with the NucleoSpin 
Gel and Polymerase Chain Reaction Clean-up kit (Macherey-
Nagel), and quantified using the Quant-iT PicoGreen dsDNA kit 
(Invitrogen). Purified polymerase chain reaction products were 
diluted to 5 ng/μL and pooled in equal amounts. The pooled ampli-
cons were purified again using Ampure magnetic purification beads 
(Agencourt) to remove short amplification products.
Illumina paired-end reads were merged using PEAR (pair-end 
read merger)21 and quality filtered with FASTX (Phred score ≥20 
for 100% of the bases in a sequence). Quality-filtered Illumina 
reads were analyzed with the software package QIIME22 (version 
1.9.0). Sequences were clustered into operational taxonomic units 
(OTUs) at a 97% identity threshold using an open-reference OTU 
picking approach with UCLUST23 against the Greengenes refer-
ence database24 (13_8 release). All sequences that failed to cluster 
when tested against the Greengenes database were used as input 
for picking OTUs de novo. Representative sequences for the OTUs 
were Greengenes reference sequences or cluster seeds and were 
taxonomically assigned using the Greengenes taxonomy and the 
Ribosomal Database Project Classifier.25 Representative OTUs were 
aligned using PyNAST26 and used to build a phylogenetic tree with 
FastTree,27 which was used to estimate α- and β-diversity of samples 
using phylogenetic diversity28 and UniFrac.29 Three-dimensional 
principal coordinates analysis plots were visualized using Emperor.30 
Chimeric sequences were identified with ChimeraSlayer31 and 
excluded from all downstream analyses. Similarly, sequences that 
could not be aligned with PyNAST, singletons, and low abundant 
sequences (relative abundance <0.002%) were also excluded. To 
correct for differences in sequencing depth, the same number of 
sequences was randomly subsampled from each sample (14 060 
sequences per sample), which excluded 3 samples because of low 
sequencing depth, and a total of 1 758 521 sequences and 571 OTUs 
were included in diversity analyses.
Statistical Analysis
Statistical analyses were done using GraphPad Prism 6 software and 
presented as mean±SEM if not otherwise stated. Two-way ANOVA 
followed by Tukey post hoc test was performed on log transformed 
data to examine the influence of 2 variables. Pearson correlation 
coefficient was calculated to test correlation of TMAO, IL-6, lesion 
size, taxa, and bile acids. Differences in microbiota composition 
based on phylogenetic distance were tested with a nonparamet-
ric test using Monte Carlo permutations, and results are presented 
as mean±SD. Statistical significance of sample grouping based on 
unweighted UniFrac was tested with a multivariate nonparametric 
analysis of variance (adonis with 999 permutations) in R. Differences 
in OTU abundance was determined with Mann-Whitney U test with 
Bonferroni correction. Differences in bile acid proportions were ana-
lyzed with Mann-Whitney U test. P<0.05 was considered as statisti-
cally significant.
Results
The effect of microbiota on the development of atherosclero-
sis is dietary dependent
Nonstandard Abbreviations and Acronyms
CONV-R conventionally raised
CVD cardiovascular disease
GF germ free
IFN-γ interferon
IL interleukin
KC/GRO keratinocyte chemoattractant/growth-regulated oncogene
OTU operational taxonomic unit
TMAO trimethylamine N-oxide
TNF-α tumor necrosis factor-α
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To address how the microbiota and diet interact to affect 
TMAO levels and atherogenesis, we fed GF and CONV-R 
male Apoe−/− mice chow or Western diet alone or supple-
mented with choline for 12 weeks. TMAO levels were barely 
detectable in GF mice on either diet and were not increased by 
choline supplementation (Figure 1A), consistent with the fact 
that the gut microbiota is required for production of the TMAO 
precursor trimethylamine from choline.32 In contrast, TMAO 
levels were significantly increased by choline supplementation 
in CONV-R mice on either diet (Figure 1A). Neither the micro-
biota nor choline supplementation had any effect on body 
weight in chow-fed mice. Epididymal fat weight was higher 
in CONV-R than GF mice but was independent of choline sup-
plementation (Figure I in the online-only Data Supplement). 
However, choline supplementation reduced body weight and 
epididymal fat weight in CONV-R but not GF mice when fed 
Western diet (Figure I in the online-only Data Supplement).
We also observed lower plasma levels of unesterified cho-
lesterol and cholesteryl esters and a trend toward higher levels 
of triacylglycerols in chow-fed CONV-R compared with GF 
Apoe−/− mice; choline supplementation did not have any addi-
tional effect (Figure 1B through 1D). In mice fed Western diet, 
neither the presence of a microbiota nor choline supplementa-
tion had any effect on plasma triacylglycerol or cholesterol 
levels (Figure 1B and 1D). Choline supplementation to a 
Western diet increased plasma levels of cholesteryl esters in 
GF but not CONV-R mice (Figure 1C).
Aortic lesions were observed in both GF and CONV-R 
Apoe−/− mice after 12 weeks on chow (range, 9728–144 033 
µm2) or Western diet (range, 51 927–165 848 µm2; Figure 2A; 
Figure II in the online-only Data Supplement). Aortic lesions 
were smaller in CONV-R compared with GF mice on chow, 
whereas there was no difference in lesion size between CONV-R 
and GF mice on a Western diet (Figure 2B). In contrast to previ-
ous findings,9 we did not observe any effect of choline supple-
mentation on lesion size in chow-fed mice (Figure 2B; Figure 
II in the online-only Data Supplement). In mice on Western 
diet, choline supplementation did not affect lesion size in GF 
mice but resulted in a greater absolute aortic lesion size in 
CONV-R mice (Figure II in the online-only Data Supplement); 
however, the lesion size normalized to vessel area was similar 
compared with GF mice and chow diet (Figure 2B). There was 
no correlation of plasma TMAO concentration with lesion size 
(Figure 2C). In contract, lesion size correlated with cholesteryl 
esters in mice fed chow but not in mice fed Western diet (Figure 
III in the online-only Data Supplement).
To investigate how sex affects the impact of gut microbiota 
and dietary choline on aortic lesions, we fed female GF and 
Figure 1. Choline and cholesterol metabolism is regulated by microbiota and diet. Plasma concentrations of trimethylamine N-oxide (TMAO; A), unesterified 
cholesterol (UC; B), cholesteryl esters (CE; C), and triacylglycerols (TAGs; D) were analyzed in Apoe−/− mice fed chow (n=10–18, left) or Western diet (n=15–
20, right) with or without supplementation of choline for 12 wk. Data are presented as mean±SEM. CONV-R indicates conventionally raised; and GF, germ 
free. Variation induced by the gut microbiota: §P<0.05, §§§§P<0.0001. Variation induced by choline: ††††P<0.0001. Post hoc multiple comparison analysis: 
*P<0.05, ****P<0.0001.
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CONV-R Apoe−/− mice chow or Western diet alone or supple-
mented with choline for 12 weeks. Female mice developed simi-
larly sized aortic lesions on both chow (30 923–197 076 µm2) 
and Western diet (100 630–220 967 µm2; Figure IV in the online-
only Data Supplement) as male mice. The effects of microbiota 
and choline on atherosclerosis were comparable with those in 
males, and, therefore, further analyses were only done in males.
In summary, lesions were smaller in CONV-R compared 
with GF Apoe−/− mice on a chow diet but not on a Western diet. 
Furthermore, the increased plasma TMAO levels observed in 
CONV-R Apoe−/− mice fed a choline-supplemented diet did 
not correlate with atherosclerotic lesion size.
Microbial and Dietary Effects on 
Inflammatory Processes
To assess whether the microbiome modulates atherosclerosis-
associated inflammation, we quantified macrophages in the 
aortic root lesions using antibodies against the glycoprotein 
CD68, which is expressed in macrophages in inflamed tissues 
(Figure 3A). The CD68-stained area was similar in GF and 
CONV-R mice on a chow diet and was not affected by choline 
supplementation (Figure 3B). In mice on a Western diet, the 
CD68-stained area was smaller in CONV-R compared with 
GF mice (P<0.01), and again, choline supplementation had no 
effect (Figure 3B).
To further study the inflammation-related response of 
microbiota and choline, 10 cytokines and chemokines were 
measured in plasma from Apoe−/− mice using a multiplex assay. 
IL-6, IL-10, KC/GRO, and TNF-α were higher in CONV-R 
compared with GF mice fed chow (Figure 3C through 3F, 
left). Higher concentrations of these cytokines, except KC/
GRO, were also observed in Western diet-fed CONV-R com-
pared with GF mice (Figure 3C through 3F, right). Note that 
several cytokines were only detected in low concentrations, 
Figure 2. Atherosclerotic lesion size is dependent on microbiota and diet. Germ-free (GF; n=10–19) and conventionally raised (CONV-R; n=12–17) Apoe−/− 
mice were fed chow (left) or Western diet (right) with or without supplementation of choline for 12 wk. Representative Oil Red O-stained aortic root sections 
are shown in A (scale bar=200 µm). The size of the aortic lesions normalized to vessel area is shown in B. Trimethylamine N-oxide (TMAO) concentrations in 
plasma were tested for correlation with aortic lesion area (C). Data are presented as mean±SEM. Variation induced by the gut microbiota: §§P<0.01. Variation 
induced by choline: †P<0.05.
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Figure 3. Microbial regulation of inflammation. Representative CD68-stained aortic root sections from Apoe−/− mice fed chow (left) or Western diet (right) 
with or without supplementation of choline are shown in A (scale bar=500 μm). CD68-stained area quantified and normalized to total vessel area is shown 
in B (n=3). Plasma cytokine concentrations of IL (interleukin)-6 (C), IL-10 (D), KC/GRO (keratinocyte chemoattractant/growth-regulated oncogene; E), and 
TNF-α (tumor necrosis factor-α; F) determined by using a multiplex assay from Meso scale (n=11–19). Data are presented as mean±SEM. CONV-R indicates 
conventionally raised; and GF, germ free. Variation induced by the gut microbiota: §P<0.05, §§P<0.01, §§§§P<0.0001. Post hoc multiple comparison analysis: 
*P<0.05. Variation induced by choline: †P<0.05.
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including IFN-γ, IL-1β, IL-2, IL-4, IL-5, and IL-12p70 (Table 
I in the online-only Data Supplement).
To conclude, the microbiota affected the plasma concen-
tration of several cytokines in both chow- and Western diet-
fed mice. CD68-stained area did not associate with aortic 
lesion size.
Diet Alters the Gut Microbiota Composition
To investigate how diet and choline supplementation affected 
the microbiota composition, we sequenced and analyzed the 
16S rRNA gene from cecal content of CONV-R Apoe−/− mice. 
Western diet-fed mice had reduced phylogenetic diversity 
compared with chow-fed mice (P=0.001), but choline supple-
mentation did not affect this parameter (Figure 4A). Principal 
coordinate analysis of the unweighted UniFrac showed that 
microbiota clustered according to chow or Western diet: 
R2=0.46 (P<0.001; Figure 4B). Supplementation with choline 
had a much smaller effect on the microbial community com-
pared with switching from chow to Western diet: chow, R2=0.07 
(P=0.003); Western diet, R2=0.11 (P=0.001; Figure 4B). We 
identified OTUs from 8 different phyla; the relative abundance 
of these phyla (with the exception of TM7) differed in mice on 
a Western diet compared with those on a chow diet (P<0.01; 
Figure 4C). Choline supplementation increased the relative 
abundance of Actinobacteria in chow-fed mice (no choline, 
0.34%; choline, 1.6%; P<0.01) but not in Western diet-fed 
mice (no choline, 0.18%; choline, 0.25%; nonsignificant) and 
did not alter the relative abundance of any other phyla.
To address whether the altered microbiota composition 
also translated to altered microbial metabolism, we assessed 
the plasma bile acid profile. Bile acids are produced from 
cholesterol in the liver and deconjugated and further 
metabolized to secondary bile acids by the gut microbi-
ota.33 Supplementation with choline increased the propor-
tion of deconjugated bile acids in plasma from CONV-R 
Apoe−/− mice on a chow diet (choline, 50.9±3.5%; no cho-
line, 34.1±4.2%; P=0.0046) and on a Western diet (choline, 
36.5±4.1%; no choline, 16.6±2.4%; P=0.0003; Figure V in 
the online-only Data Supplement). In contrast, supplemen-
tation with choline only increased the proportion of second-
ary bile acids in plasma from CONV-R Apoe−/− mice on a 
Western diet (choline, 34.0±2.5%; no choline, 19.2±1.9%; 
P=0.0002; Figure V in the online-only Data Supplement). 
As expected, we only observed primary and conjugated 
bile acids in plasma from GF Apoe−/− mice (Figure V in the 
online-only Data Supplement).
Choline supplementation also altered the abundance of 
4 and 6 OTUs, all belonging to the order Clostridiales, in 
chow- and Western diet-fed mice, respectively (Figure VI 
in the online-only Data Supplement; Table II in the online-
only Data Supplement). These OTUs were also found to 
be significantly correlated, both positively and negatively, 
Figure 4. Global community structure of microbiota in cecal content from chow and Western diet-fed mice. Microbial composition was determined in con-
ventionally raised Apoe−/− mice fed chow or Western diet with or without choline for 12 wk (n=13–18) by sequencing 16S rRNA genes. Alpha diversity mea-
surements with rarefaction curves using phylogenetic distance as rarefaction measure showing mean±SD in mice fed chow: no choline (orange) and choline 
(green); or Western diet: no choline (red) and choline (blue; A). Principal coordinate analysis plot with the 2 major components determining the microbial 
gene profile based on unweighted UniFrac (B). Each dot represents a cecal content sample from 1 mouse fed chow with no choline (orange) or choline 
(green) and Western diet with no choline (red) or choline (blue). Mean relative abundance of the 8 different phyla present in the cecal content (C). **P<0.01 
indicates difference induced by choline determined by Mann-Whitney U test with Bonferroni correction. Variation induced by the diet for all phyla except 
TM7: §§P<0.01.
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with plasma TMAO concentrations and some of the cho-
line-regulated bile acids (Table II in the online-only Data 
Supplement) but not with aortic lesion size (nonsignificant, 
data not shown).
To conclude, the macronutrient composition of the 
diet had large effects on the overall microbial composi-
tion, confirming previous data. In addition, choline sup-
plementation also affected the microbial composition but 
to a much lower extent than switching between chow and 
Western diet.
Discussion
In this study, we demonstrated that the impact of the gut 
microbiota on the development of atherosclerosis is dietary 
dependent. Atherosclerotic lesion size and plasma cho-
lesterol levels were lower in CONV-R compared with GF 
Apoe−/− mice on a chow diet but not on a Western diet. 
Furthermore, we showed that choline supplementation, 
which promoted increased TMAO levels in CONV-R but 
not GF mice, did not affect lesion size in chow-fed mice. 
In mice on a Western diet, choline supplementation did not 
alter the normalized aortic lesion size but decreased body 
weight and body fat in CONV-R but not GF mice. Thus 
suggesting that microbial metabolism of choline may have 
additional effects on host metabolism in agreement with 
earlier studies.34
In agreement with previous findings, we showed that the 
effect of gut microbiota on atherosclerosis is dietary depen-
dent,11 and atherosclerotic lesions develop regardless of micro-
bial status.35 We found that lesion size in the Apoe−/− mouse 
model paralleled plasma cholesterol levels in a microbiota-
dependent fashion, that is, chow-fed CONV-R mice had both 
lower plasma cholesterol levels and smaller aortic lesions than 
GF mice. We, therefore, hypothesize that the microbiota is 
protective on fiber-rich chow diet through production of ben-
eficial metabolites, such as short-chain fatty acids, that may 
reduce cholesterol levels.8
Dietary choline and plasma TMAO levels have previ-
ously been shown to associate with an increased risk for 
CVD.9,12,36 A recent study showed that inhibition of trimeth-
ylamine lyases—enzymes expressed by gut microbes that 
convert choline to trimethylamine—reduces atheroscle-
rosis in mice,37 and thus, microbial regulation of choline 
has been proposed to be important in the development of 
atherosclerosis. We showed that choline supplementation 
promoted an increase in plasma TMAO levels in chow-fed 
CONV-R mice but did not affect aortic lesion size or mac-
rophage content, plasma cholesterol, or cytokine levels. 
In Western diet-fed mice, choline supplementation had no 
effect on normalized aortic lesion size and did not affect 
plasma cholesterol.38
Our results contrast with previous publications demon-
strating a clear association between choline/carnitine diets 
and atherosclerosis.9,12 This discrepancy may be because 
of different experimental setups. In previous studies, anti-
biotics were administered to deplete the gut microbiota, 
and choline supplementation was started at weaning (aged 
around 4 weeks).9,12 Here, we used GF mice, which are born 
and raised under sterile conditions, and we supplemented 
choline at 8 weeks of age when atherosclerotic disease 
already started to develop.39 Therefore, we cannot exclude 
that dietary choline may be an important factor at an early-
stage atherosclerosis development. Consistent with this pos-
sibility, a recent study showed that female Apoe−/− mice with 
hypercholesterolemic mothers develop larger aortic root 
lesions compared with mice with normocholesterolemic 
mothers—an effect that was associated with TMAO levels 
in the offspring.40
Interestingly, CD68-stained macrophage content in aor-
tic lesions was not associated with lesion size when mice 
were fed chow diet, and thus, we did not observe increased 
abundance of CD68-positive macrophages in GF mice, 
despite larger lesions compared with CONV-R mice. In 
contrast, GF mice had increased CD68 content compared 
with CONV-R mice when fed Western diet, despite similar 
plaque size. These findings are in agreement with our obser-
vation that GF mice had elevated cholesterol levels and that 
cholesterol crystals may form sterile inflammation by acti-
vating inflammasomes.41
We did not observe any effects of choline on accumula-
tion of CD68-positive macrophages in the plaque, which is in 
contrast to a previous study, demonstrating that inflammation 
markers and CD68 mRNA were increased in aorta in low-
density lipoprotein receptor knockout mice receiving choline 
in the drinking water.42 These differences could reflect differ-
ent time points in atherosclerosis development because Seldin 
et al42 studied mice treated with choline for 3 weeks, whereas 
we studied mice treated with choline for 12 weeks or that we 
used different animal models. However, we found that several 
cytokines were microbially regulated, which may reflect an 
immune response mediated by colonization of the gut but is 
not sufficient to affect atherosclerosis. Rather, atherosclerosis 
development in our model was more associated with choles-
terol levels.
The diet has a large impact on the gut microbiota composi-
tion and physiology, and shifting the diet from a low-fat, fiber-
rich to a high-fat, high-sugar Western diet rapidly changes the 
microbiome, even within a day.43,44 In this study, the macronu-
trient composition of the diet was the most important factor 
influencing the overall composition of the gut microbiota, and 
we observed distinct clustering of chow- and Western diet-fed 
mice. Dietary choline had smaller effects on global commu-
nity structure although some taxa belonging to Clostridiales, 
which have previously been shown to correlate with TMAO 
and aortic lesion size,37 were either downregulated or upregu-
lated and associated with TMAO levels but not aortic lesion 
size. Interestingly, we observed that choline supplementa-
tion affected bile acid profile, suggesting that despite minor 
taxonomic effects, choline may affect the functionality of the 
microbiome.
In conclusion, we demonstrate that the development of 
atherosclerosis in Apoe−/− mice is associated with the mac-
ronutrient composition of the diet and cholesterol levels, and 
there is no evidence that interaction between the gut micro-
biota and dietary choline further promotes atherogenesis. 
Importantly, in this atherosclerosis model, the gut microbiota 
reduces atherogenesis, but interaction with the diet can influ-
ence the disease process.
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Highlights
• The interaction between gut microbiota and diet affects atherogenesis, and conventionally raised mice develop smaller lesions compared with 
germ-free mice on chow diet but not Western diet.
• Plasma cholesterol levels, but not trimethylamine N-oxide, are associated with aortic lesion sizes.
• Inflammation markers are influenced by the interaction of the macronutrient composition of the dietand gut microbiota.
• The macronutrient composition of the diet determines the gut microbiota composition, and choline alters the abundance of several operational 
taxonomic units belonging to the order Clostridiales.
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